CARLSBAD, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Visage Imaging(R), Inc., a wholly owned subsidiary of Mercury Computer Systems, Inc. (NASDAQ: MRCY), announced that it has received FDA 510(k) clearance to market its latest thin client product release, Visage CS 3.1. This release brings significant enhancements to its prior offerings in cardiac and other tools, and includes new optional Neuroradiology and Oncology applications. The Neuro option facilitates brain perfusion analysis in CT and MRI imaging, while the Oncology option provides tools for analyzing, documenting, and comparing lesions for multiple modalities, including Standardized Update Value (SUV)- based analysis for PET-CT.
"Visage Imaging's thin client solution instantly brings workstation-class diagnostic tools to the numerous workplaces of those who need them," said Hartmut Schirmacher, Director of Product Management for Visage Imaging. "Compared to typical workstations or other web-based 'fat' solutions, Visage CS offers far superior performance across the board, especially when viewing and processing large data volumes. Furthermore, Visage CS 3.1 will affordably allow for broader access to state-of-the-art applications throughout the enterprise."
In addition to the new application options, Visage CS 3.1 features numerous new and streamlined measurement and post processing tools such as advanced 3D segmentation, ROI-based analysis and time-value curves, and improved editing of cardiac LV models.
Visage Imaging, Inc. - Visioneering Science for Life(R)
Visage Imaging, Inc. (www.visageimaging.com) designs and engineers clinical products that present its customers with the ability to overcome demanding market challenges and improve diagnostic results with accuracy and expedience. As a wholly owned subsidiary of Mercury Computer Systems, Inc., Visage Imaging incorporates Mercury's 20+ years of technical expertise and deep knowledge of the science behind diagnostic applications into its practice, and leverages this experience to push the boundaries of what is possible within its domain.
Through collaborative learning, Visage Imaging has built a nimble, creative organization: one that is first to market with innovative 3D clinical applications, offers best-in-class 3D products that are unique and reliable, and helps its customers to accelerate their own market innovation and clinical benefit.
Forward-Looking Safe Harbor Statement
This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the FDA 510(k) clearance for Visage Imaging to market its latest thin client product release, Visage CS 3.1. You can identify these statements by our use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, general economic and business conditions, including unforeseen weakness in Visage Imaging's markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, continued funding of defense programs, the timing of such funding, changes in the U.S. Government's interpretation of federal procurement rules and regulations, market acceptance of Visage Imaging's products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, and difficulties in retaining key customers. These risks and uncertainties also include such additional risk factors as are discussed in Mercury Computer Systems, Inc.'s recent filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2008. Visage Imaging cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Visage Imaging undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.
Contacts: Diane M. Clifford, Director of Global Marketing Visage Imaging, Inc. Phone: 978-967-1168 E-mail: firstname.lastname@example.org Kathleen Sniezek, Corporate Public Relations Manager Mercury Computer Systems, Inc. Phone: 978-967-1126 E-mail: email@example.com
Visage, Visage Imaging, and Visioneering Science for Life are registered trademarks of Mercury Computer Systems, Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective holders.
|SOURCE Mercury Computer Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved